LTLeena Tiitto

Leena Tiitto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Leena Tiitto has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Arne Holmgren

    Department of Medical Biochemistry and Biophysics, Medical Nobel Institute for Biochemistry, Karolinska Institutet, SE‐17177, Stockholm, Sweden

    1 shared publication
  • P Paakko

    Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland

    1 shared publication
  • Paavo Pääkkö

    Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland

    1 shared publication
  • R Bloigu

    Medical Informatics Group, University of Oulu and Oulu University Hospital, Oulu, Finland

    1 shared publication
  • R Kaarteenaho-Wiik

    Department of Internal Medicine/Division of Pulmonary Diseases, University of Oulu and Oulu University Hospital, Oulu, Finland

    1 shared publication
  • Raija Sormunen

    Biocenter Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland

    1 shared publication

Latest Publications

  • Open Access

    Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia

    by L Tiitto, R Bloigu, U Heiskanen, P Paakko, V L Kinnula, R Kaarteenaho-Wiik

    Background: Fibroblastic focus (FF) is the typical histopathological feature of idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia (UIP). A study was undertaken to analyse FF at diagnosis, to analyse the histopathological findings at necropsy, and to examine their association with the course of the disease. Methods: A retrospective study was made of 76 UIP cases collected over a period of 30 years from one university hospital; 64 had idiopathic IPF. The surface area of one slide of each lung biopsy specimen was defined by image analysis and the total number of FF was quantified. The histological features of necroscopic lung samples were re-analysed in 11 cases. Clinical follow up information was obtained from the registers. Results: Patients with ⩽50 FF/cm2 (n = 34) in the lung biopsy specimen had a median survival of 89 months (95% CI 38 to 140) compared with 49 months (95% CI 36 to 62) in those with >50 FF/cm2 (n = 42, p = 0.0358). Diffuse alveolar damage (DAD) was detected in 10 necropsy samples and almost prevented the histopathological confirmation of UIP in six cases. Accumulation of neutrophils occurred in nine cases. There was no association between FF at diagnosis and DAD at necropsy, or between FF and exacerbation of the disease before death. Conclusions: The number of FF in lung samples before death is associated with poor survival but not with DAD, which is a common feature in necropsy specimens of patients with UIP. FF cannot predict an acute exacerbation of IPF.


  • Expression of the thioredoxin system in interstitial lung disease

    by Leena Tiitto, Riitta Kaarteenaho‐Wiik, Raija Sormunen, Arne Holmgren, Paavo Pääkkö, Ylermi Soini, Vuokko L Kinnula

    The thioredoxin system containing thioredoxin (Trx) and thioredoxin reductase (TrxR) has profound effects on cell proliferation and protection against exogenous oxidants. The significance of the Trx system in human lung and lung diseases is, however, largely unresolved. Altogether, 66 specimens of human lung were investigated by immunohistochemistry for their expression of Trx and TrxR. The diseases included interstitial pneumonias such as usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), and UIP associated with collagen vascular diseases (CVD‐ILD), and granulomatous diseases such as sarcoidosis and allergic alveolitis. The ultrastructural localization of Trx and TrxR was analysed by immunoelectron microscopy. In healthy lung, Trx and TrxR were expressed in bronchial epithelium and alveolar macrophages. Trx and TrxR were highly concentrated in areas of metaplastic epithelium in UIP and in alveolar macrophages in DIP, though fibrotic areas in UIP were mainly negative. The expression of both enzymes was clearly weaker in CVD‐ILD than in UIP. Granulomas of sarcoidosis showed moderate to intense Trx immunoreactivity. Ultrastructurally, Trx and TrxR were expressed diffusely in the cytosolic compartment and plasma membrane of metaplastic type II pneumocytes, macrophages, and bronchial epithelial cells. This study highlights the importance of Trx and TrxR in primary defence in bronchial epithelium, alveolar epithelium, and macrophages in human lung, but also indicates that elevated expression of these proteins may serve as markers of ongoing cell regeneration and inflammation. Copyright © 2003 John Wiley & Sons, Ltd.